3B Blackbio Dx Limited (NSE:3BBLACKBIO)

3B Blackbio Dx Revenue

In the fiscal year ending March 31, 2026, 3B Blackbio Dx had annual revenue of 1.42B INR with 47.11% growth. 3B Blackbio Dx had revenue of 354.34M in the quarter ending March 31, 2026, with 57.52% growth.

• Revenue: 1.42B
• Revenue Growth: +47.11%
• P/S Ratio: 7.56
• Revenue / Employee: 16.70M
• Employees: 85
• Market Cap: 10.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.42B	454.50M	47.11%
Mar 31, 2025	964.69M	220.55M	29.64%
Mar 31, 2024	744.13M	123.45M	19.89%
Mar 31, 2023	620.68M	-254.81M	-29.11%
Mar 31, 2022	875.50M	-1.42B	-61.87%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error